Report Detail
Global Cancer Microbiome Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4546289 |
- 02 August, 2023 |
- Global |
- 102 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Cancer Microbiome Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cancer Microbiome Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cancer Microbiome Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cancer Microbiome Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cancer Microbiome Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cancer Microbiome Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Microbiome Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Microbiome Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding and Micronoma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cancer Microbiome Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Next Generation Sequencing
Polymerase Chain Reaction
Market segment by Application
Hospitals
Clinic
Others
Market segment by players, this report covers
CD Genomics
Eurofins Scientific
Illumina
Prescient Medicine Holding
Micronoma
Novogene
Oxford Nanopore Technologies
Pacific Biosciences
Qiagen
Therma Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Microbiome Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Microbiome Testing, with revenue, gross margin and global market share of Cancer Microbiome Testing from 2018 to 2023.
Chapter 3, the Cancer Microbiome Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cancer Microbiome Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Microbiome Testing.
Chapter 13, to describe Cancer Microbiome Testing research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Cancer Microbiome Testing
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Cancer Microbiome Testing by Type
- 1.3.1 Overview: Global Cancer Microbiome Testing Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Cancer Microbiome Testing Consumption Value Market Share by Type in 2022
- 1.3.3 Next Generation Sequencing
- 1.3.4 Polymerase Chain Reaction
- 1.4 Global Cancer Microbiome Testing Market by Application
- 1.4.1 Overview: Global Cancer Microbiome Testing Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Cancer Microbiome Testing Market Size & Forecast
- 1.6 Global Cancer Microbiome Testing Market Size and Forecast by Region
- 1.6.1 Global Cancer Microbiome Testing Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Cancer Microbiome Testing Market Size by Region, (2018-2029)
- 1.6.3 North America Cancer Microbiome Testing Market Size and Prospect (2018-2029)
- 1.6.4 Europe Cancer Microbiome Testing Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Cancer Microbiome Testing Market Size and Prospect (2018-2029)
- 1.6.6 South America Cancer Microbiome Testing Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Cancer Microbiome Testing Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 CD Genomics
- 2.1.1 CD Genomics Details
- 2.1.2 CD Genomics Major Business
- 2.1.3 CD Genomics Cancer Microbiome Testing Product and Solutions
- 2.1.4 CD Genomics Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 CD Genomics Recent Developments and Future Plans
- 2.2 Eurofins Scientific
- 2.2.1 Eurofins Scientific Details
- 2.2.2 Eurofins Scientific Major Business
- 2.2.3 Eurofins Scientific Cancer Microbiome Testing Product and Solutions
- 2.2.4 Eurofins Scientific Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Eurofins Scientific Recent Developments and Future Plans
- 2.3 Illumina
- 2.3.1 Illumina Details
- 2.3.2 Illumina Major Business
- 2.3.3 Illumina Cancer Microbiome Testing Product and Solutions
- 2.3.4 Illumina Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Illumina Recent Developments and Future Plans
- 2.4 Prescient Medicine Holding
- 2.4.1 Prescient Medicine Holding Details
- 2.4.2 Prescient Medicine Holding Major Business
- 2.4.3 Prescient Medicine Holding Cancer Microbiome Testing Product and Solutions
- 2.4.4 Prescient Medicine Holding Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Prescient Medicine Holding Recent Developments and Future Plans
- 2.5 Micronoma
- 2.5.1 Micronoma Details
- 2.5.2 Micronoma Major Business
- 2.5.3 Micronoma Cancer Microbiome Testing Product and Solutions
- 2.5.4 Micronoma Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Micronoma Recent Developments and Future Plans
- 2.6 Novogene
- 2.6.1 Novogene Details
- 2.6.2 Novogene Major Business
- 2.6.3 Novogene Cancer Microbiome Testing Product and Solutions
- 2.6.4 Novogene Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Novogene Recent Developments and Future Plans
- 2.7 Oxford Nanopore Technologies
- 2.7.1 Oxford Nanopore Technologies Details
- 2.7.2 Oxford Nanopore Technologies Major Business
- 2.7.3 Oxford Nanopore Technologies Cancer Microbiome Testing Product and Solutions
- 2.7.4 Oxford Nanopore Technologies Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Oxford Nanopore Technologies Recent Developments and Future Plans
- 2.8 Pacific Biosciences
- 2.8.1 Pacific Biosciences Details
- 2.8.2 Pacific Biosciences Major Business
- 2.8.3 Pacific Biosciences Cancer Microbiome Testing Product and Solutions
- 2.8.4 Pacific Biosciences Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Pacific Biosciences Recent Developments and Future Plans
- 2.9 Qiagen
- 2.9.1 Qiagen Details
- 2.9.2 Qiagen Major Business
- 2.9.3 Qiagen Cancer Microbiome Testing Product and Solutions
- 2.9.4 Qiagen Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Qiagen Recent Developments and Future Plans
- 2.10 Therma Fisher Scientific
- 2.10.1 Therma Fisher Scientific Details
- 2.10.2 Therma Fisher Scientific Major Business
- 2.10.3 Therma Fisher Scientific Cancer Microbiome Testing Product and Solutions
- 2.10.4 Therma Fisher Scientific Cancer Microbiome Testing Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Therma Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Cancer Microbiome Testing Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Cancer Microbiome Testing by Company Revenue
- 3.2.2 Top 3 Cancer Microbiome Testing Players Market Share in 2022
- 3.2.3 Top 6 Cancer Microbiome Testing Players Market Share in 2022
- 3.3 Cancer Microbiome Testing Market: Overall Company Footprint Analysis
- 3.3.1 Cancer Microbiome Testing Market: Region Footprint
- 3.3.2 Cancer Microbiome Testing Market: Company Product Type Footprint
- 3.3.3 Cancer Microbiome Testing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Cancer Microbiome Testing Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Cancer Microbiome Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Cancer Microbiome Testing Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Cancer Microbiome Testing Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Cancer Microbiome Testing Consumption Value by Type (2018-2029)
- 6.2 North America Cancer Microbiome Testing Consumption Value by Application (2018-2029)
- 6.3 North America Cancer Microbiome Testing Market Size by Country
- 6.3.1 North America Cancer Microbiome Testing Consumption Value by Country (2018-2029)
- 6.3.2 United States Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 6.3.3 Canada Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Cancer Microbiome Testing Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Cancer Microbiome Testing Consumption Value by Type (2018-2029)
- 7.2 Europe Cancer Microbiome Testing Consumption Value by Application (2018-2029)
- 7.3 Europe Cancer Microbiome Testing Market Size by Country
- 7.3.1 Europe Cancer Microbiome Testing Consumption Value by Country (2018-2029)
- 7.3.2 Germany Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 7.3.3 France Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 7.3.5 Russia Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 7.3.6 Italy Cancer Microbiome Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Cancer Microbiome Testing Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Cancer Microbiome Testing Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Cancer Microbiome Testing Market Size by Region
- 8.3.1 Asia-Pacific Cancer Microbiome Testing Consumption Value by Region (2018-2029)
- 8.3.2 China Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 8.3.3 Japan Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 8.3.5 India Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 8.3.7 Australia Cancer Microbiome Testing Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Cancer Microbiome Testing Consumption Value by Type (2018-2029)
- 9.2 South America Cancer Microbiome Testing Consumption Value by Application (2018-2029)
- 9.3 South America Cancer Microbiome Testing Market Size by Country
- 9.3.1 South America Cancer Microbiome Testing Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Cancer Microbiome Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Cancer Microbiome Testing Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Cancer Microbiome Testing Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Cancer Microbiome Testing Market Size by Country
- 10.3.1 Middle East & Africa Cancer Microbiome Testing Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Cancer Microbiome Testing Market Size and Forecast (2018-2029)
- 10.3.4 UAE Cancer Microbiome Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Cancer Microbiome Testing Market Drivers
- 11.2 Cancer Microbiome Testing Market Restraints
- 11.3 Cancer Microbiome Testing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Cancer Microbiome Testing Industry Chain
- 12.2 Cancer Microbiome Testing Upstream Analysis
- 12.3 Cancer Microbiome Testing Midstream Analysis
- 12.4 Cancer Microbiome Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cancer Microbiome Testing. Industry analysis & Market Report on Cancer Microbiome Testing is a syndicated market report, published as Global Cancer Microbiome Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cancer Microbiome Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
